Previous data showed that serum LPS, liver TLR4-mRNA, and serum inflammatory cytokines in a probiotics intervention group were all significantly decreased compared to that in the NAFLD model group. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatotic liver disease.